NO980649L - Bioconjugates of manganese complexes and their use as catalysts - Google Patents

Bioconjugates of manganese complexes and their use as catalysts

Info

Publication number
NO980649L
NO980649L NO980649A NO980649A NO980649L NO 980649 L NO980649 L NO 980649L NO 980649 A NO980649 A NO 980649A NO 980649 A NO980649 A NO 980649A NO 980649 L NO980649 L NO 980649L
Authority
NO
Norway
Prior art keywords
bioconjugates
catalysts
manganese complexes
mimicking
sod
Prior art date
Application number
NO980649A
Other languages
Norwegian (no)
Other versions
NO980649D0 (en
Inventor
William L Neumann
Dennis P Riley
Randy H Weiss
Susan L Henke
Patrick J Lennon
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of NO980649D0 publication Critical patent/NO980649D0/en
Publication of NO980649L publication Critical patent/NO980649L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic System
    • C07F13/005—Compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D259/00—Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Abstract

Biokonjugater av lavmolekylvekt etterligninger av superoksid dismutase (SOD) representert ved formel (I): hvori R, R1, R,, R1,, R2, R'2, R3, R'3, R,,, R'4) R5> R'5) R^, R'6, R7, R'7> R8, R'8> Rg, R'9, X, Y, Z og n er definert heri, er nyttige som terapeutiske midler for inflammatoriske sykdomstilstander og forstyrrelser, så som ischemi/reperfusjonsskade, slag, aterosklerose og alle andre tilstander med oksidant- indusert vevsskade eller andre skader.Low-molecular-weight bioconjugates mimicking superoxide dismutase (SOD) represented by formula (I): wherein R, R1, R ,, R1, R2, R'2, R3, R'3, R ,,, R'4) R5> R'5) R6, R'6, R7, R'7> R8, R'8> Rg, R'9, X, Y, Z and n are defined herein as useful as therapeutic agents for inflammatory disease states and disorders , such as ischemia / reperfusion injury, stroke, atherosclerosis and all other conditions with oxidant-induced tissue injury or other damage.

NO980649A 1995-08-17 1998-02-16 Bioconjugates of manganese complexes and their use as catalysts NO980649L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US242195P 1995-08-17 1995-08-17
PCT/US1996/012767 WO1997006824A2 (en) 1995-08-17 1996-08-14 Bioconjugates of manganese complexes and their application as catalysts

Publications (2)

Publication Number Publication Date
NO980649D0 NO980649D0 (en) 1998-02-16
NO980649L true NO980649L (en) 1998-04-02

Family

ID=21700675

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980649A NO980649L (en) 1995-08-17 1998-02-16 Bioconjugates of manganese complexes and their use as catalysts

Country Status (12)

Country Link
EP (1) EP0844886A2 (en)
JP (1) JP2000513322A (en)
KR (1) KR19990037647A (en)
CN (1) CN1200039A (en)
AU (1) AU700958B2 (en)
BR (1) BR9610347A (en)
CA (1) CA2229799A1 (en)
CZ (1) CZ39898A3 (en)
IL (1) IL123040A0 (en)
NO (1) NO980649L (en)
PL (1) PL324993A1 (en)
WO (1) WO1997006824A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2254142T3 (en) 1999-01-25 2006-06-16 National Jewish Medical And Research Center REPLACED PORPHIRINS AND THEIR THERAPEUTIC USE.
US6749832B2 (en) 1999-12-23 2004-06-15 Amersham Plc Labelled ascorbic acid derivatives
US20050176790A1 (en) 2001-02-28 2005-08-11 Johannes Bartholomaus Pharmaceutical salts
EP1439842A4 (en) 2001-06-01 2009-09-02 Nat Jewish Med & Res Center Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
KR20140001257A (en) 2008-05-13 2014-01-06 유니버시티 오브 캔사스 Metal abstraction peptide(map) tag and associated methods
RU2506083C2 (en) 2008-05-23 2014-02-10 Нэшнл Джуиш Хелт Method of treating disorders associated with alkylating agent exposure
CN103906756B (en) * 2011-09-26 2020-03-03 加莱拉实验室有限责任公司 Methods for treating diseases
WO2013181461A2 (en) 2012-06-01 2013-12-05 University Of Kansas Metal abstraction peptide with superoxide dismutase activity
AU2018221043A1 (en) * 2017-02-15 2019-09-12 Galera Labs, Llc Pentaaza macrocyclic ring complexes for local intestinal delivery
CN108752383B (en) * 2018-05-02 2020-10-30 江苏理工学院 Pyrazole carboxylate manganese complex with SOD activity and preparation method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0281463A3 (en) * 1987-03-06 1989-01-25 Sumitomo Pharmaceuticals Company, Limited Platinum complex, process for its preparation and pharmaceutical composition including such a complex
ATE164164T1 (en) * 1991-07-19 1998-04-15 Monsanto Co MANGANEOUS COMPLEXES WITH NITROGEN-CONTAINING MACROCYCLIC LIGANDS, ACTIVE AS SUPEROXIDE DISMUTASE CATALYSTS.
US6204259B1 (en) * 1993-01-14 2001-03-20 Monsanto Company Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
CN1152880A (en) * 1994-04-22 1997-06-25 孟山都公司 Diagnostic image analysis with metal complexes
US6525041B1 (en) * 1995-06-06 2003-02-25 Pharmacia Corporation Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
AU5928396A (en) * 1995-06-07 1996-12-30 Monsanto Company Process for preparing substituted polyazamacrocycles

Also Published As

Publication number Publication date
WO1997006824A2 (en) 1997-02-27
EP0844886A2 (en) 1998-06-03
IL123040A0 (en) 1998-09-24
CA2229799A1 (en) 1997-02-27
AU700958B2 (en) 1999-01-14
MX9801322A (en) 1998-05-31
JP2000513322A (en) 2000-10-10
BR9610347A (en) 1999-06-01
AU6765596A (en) 1997-03-12
NO980649D0 (en) 1998-02-16
WO1997006824A3 (en) 1997-07-03
CN1200039A (en) 1998-11-25
CZ39898A3 (en) 1998-07-15
PL324993A1 (en) 1998-07-06
KR19990037647A (en) 1999-05-25

Similar Documents

Publication Publication Date Title
DK0679155T3 (en) Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismantling superoxide
CA2072934A1 (en) Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
ATE164164T1 (en) MANGANEOUS COMPLEXES WITH NITROGEN-CONTAINING MACROCYCLIC LIGANDS, ACTIVE AS SUPEROXIDE DISMUTASE CATALYSTS.
BG106390A (en) Novel spiro compounds
CA2224060A1 (en) Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
MA28010A1 (en) PIPERAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS
IL173032A0 (en) Pyridazine derivatives and their use as therapeutic agents
TR200000482T2 (en) N-Aroylphenylalanine derivatives.
FI964773A0 (en) (a) annealed pyrrole derivatives and their use in pharmacin
ES2133430T3 (en) DERIVATIVES OF N-HETEROARIL-N-FENILUREA, ITS PREPARATION AND USE.
PT928788E (en) PHARMACEUTICALLY ACTIVE COMPOUNDS
FI964771A0 (en) (a) annealed pyrrole derivatives and their use in pharmacin
NO980649L (en) Bioconjugates of manganese complexes and their use as catalysts
NO972726D0 (en) Tricyclic compounds
ATE213387T1 (en) N-ARYLHYDRAZINE DERIVATIVES AS INSECTICIDES AND ACARICIDES
FI924725A (en) ANTI-INFLAMMATOR HYDROXIAMINSYROR OCH N-HYDROXIUREOR
TR200201128T2 (en) Tetrahydrothiopyraniphalazinone derivatives as PDE4 inhibitors.
NO984164L (en) Bioconjugates of manganese or iron complexes consisting of nitrogen-containing macrocyclic ligands effective as catalysts for the dismutation of superoxide
DE69530988D1 (en) BENZIMIDAZOLE DERIVATIVES WITH DOPAMINERIC EFFECT
NO984165L (en) Iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxides
CA2231812A1 (en) Cyclic nitrones and pharmaceutical compositions containing them
ATE153657T1 (en) CYCLIC BENZYLAMINO, BENZYLAMIDO AND BENZYLIMIDO DERIVATIVES AS ANTIPSYCHOTIC ACTIVES
DE69504272T2 (en) N-arylthiohydrazone derivatives as insecticidal and acaracidal agents
NZ332029A (en) Sulfonamide substituted chromans, process for their preparation, their use as a medicament and pharmaceutical preparations comprising them
MX9706944A (en) Quinuclidines substituted with tetrazolyl as antagonist of the substance p.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application